AIBS has provided testimony to the House Appropriations Committee regarding fiscal year 2026 funding for biological research programs within the Smithsonian Institution, the U.S. Geological Survey, the U.S. Fish and Wildlife Service, and the Environmental Protection Agency.

Please take a few moments to call and write to your members of Congress about protecting the Institute of Museum and Library Services from harmful funding and staffing cuts.

AIBS has signed on to letters supporting increased funding for the Agricultural Research Service, the Agricultural and Food Research Initiative, as well as Agriculture Advanced Research and Development Authority in FY 2026.

AIBS has joined the Natural Science Collections Alliance and 72 other professional societies and organizations in sending a letter to Congress expressing deep concern regarding the March 14 Executive Order targeting the Institute of Museum and Library Services (IMLS) for elimination.

The latest Public Policy Report has been released. Congress enacts full-year continuing resolution, NASA shuts down Chief Scientist office, EPA plans to gut science office, and other news.

AIBS has joined a coalition of 34 scientific and medical organizations to issue a unified statement on the impact and safety of vaccines, emphasizing the critical role of vaccinations in public health.

The Coalition for National Science Funding (CNSF), of which AIBS is a member, has written to appropriators urging them to provide at least $9.9 billion for the National Science Foundation (NSF) in fiscal year 2026.

AIBS and the Southeastern Universities Research Association (SURA) are pleased to announce that Anna Rader Groves has been selected for the 2025 AIBS & SURA Public Policy Fellowship.

The latest Public Policy Report has been released. NSF reinstates 84 probationary employees, Trump moves to relocate federal agencies, Administration disbands key advisory panels, and other news.

AIBS has sent a joint stakeholder letter to congressional leaders urging them to oppose recent executive actions that are harming the U.S. scientific enterprise.